153 related articles for article (PubMed ID: 31562255)
21. Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells.
Nakamura K; Sawada K; Kinose Y; Yoshimura A; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Morishige KI; Kurachi H; Lengyel E; Kimura T
Mol Cancer Res; 2017 Jan; 15(1):78-92. PubMed ID: 27758876
[TBL] [Abstract][Full Text] [Related]
22. [Screening of targeting peptides for highly metastatic human ovarian cancer cells and their effect on the biological behavior of ovarian cancer cells].
Zhou C; Kang J; Wang X; Nie M; Jiang W
Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):565-70. PubMed ID: 25430020
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis.
McGuire S; Kara B; Hart PC; Montag A; Wroblewski K; Fazal S; Huang XY; Lengyel E; Kenny HA
Gynecol Oncol; 2019 May; 153(2):405-415. PubMed ID: 30797592
[TBL] [Abstract][Full Text] [Related]
24. Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis.
Mitra AK; Chiang CY; Tiwari P; Tomar S; Watters KM; Peter ME; Lengyel E
Oncogene; 2015 Nov; 34(48):5923-32. PubMed ID: 25798837
[TBL] [Abstract][Full Text] [Related]
25. TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer.
Gao C; Yao H; Liu H; Feng Y; Yang Z
BMC Cancer; 2019 Mar; 19(1):237. PubMed ID: 30876464
[TBL] [Abstract][Full Text] [Related]
26. Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer.
Samardzija C; Luwor RB; Quinn MA; Kannourakis G; Findlay JK; Ahmed N
BMC Cancer; 2016 Jul; 16():432. PubMed ID: 27390927
[TBL] [Abstract][Full Text] [Related]
27. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.
Iljin K; Ketola K; Vainio P; Halonen P; Kohonen P; Fey V; Grafström RC; Perälä M; Kallioniemi O
Clin Cancer Res; 2009 Oct; 15(19):6070-8. PubMed ID: 19789329
[TBL] [Abstract][Full Text] [Related]
28. A 3D tumor microenvironment regulates cell proliferation, peritoneal growth and expression patterns.
Loessner D; Rockstroh A; Shokoohmand A; Holzapfel BM; Wagner F; Baldwin J; Boxberg M; Schmalfeldt B; Lengyel E; Clements JA; Hutmacher DW
Biomaterials; 2019 Jan; 190-191():63-75. PubMed ID: 30396040
[TBL] [Abstract][Full Text] [Related]
29. Mesothelial Cell HIF1α Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk.
Hart PC; Kenny HA; Grassl N; Watters KM; Litchfield LM; Coscia F; Blaženović I; Ploetzky L; Fiehn O; Mann M; Lengyel E; Romero IL
Cell Rep; 2019 Dec; 29(12):4086-4098.e6. PubMed ID: 31851935
[TBL] [Abstract][Full Text] [Related]
30. Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness.
Cai J; Tang H; Xu L; Wang X; Yang C; Ruan S; Guo J; Hu S; Wang Z
Carcinogenesis; 2012 Jan; 33(1):20-9. PubMed ID: 22021907
[TBL] [Abstract][Full Text] [Related]
31. Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum.
Nakamura M; Ono YJ; Kanemura M; Tanaka T; Hayashi M; Terai Y; Ohmichi M
Gynecol Oncol; 2015 Nov; 139(2):345-54. PubMed ID: 26335595
[TBL] [Abstract][Full Text] [Related]
32. 1-calcium phosphate-uracil inhibits intraperitoneal metastasis by suppressing FAK in epithelial ovarian cancer.
Peng J; Yang X; Li X; Gao H; Liu N; Guo X
Cell Cycle; 2019 Aug; 18(16):1925-1937. PubMed ID: 31290719
[TBL] [Abstract][Full Text] [Related]
33. Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.
Hart PC; Bajwa P; Kenny HA
Adv Exp Med Biol; 2021; 1330():75-94. PubMed ID: 34339031
[TBL] [Abstract][Full Text] [Related]
34. MiR-15a-3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1.
Fan B; Chen LP; Yuan YH; Xiao HN; Lv XS; Xia ZY
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1934-1946. PubMed ID: 30915736
[TBL] [Abstract][Full Text] [Related]
35. U-77,863: a novel cinnanamide isolated from Streptomyces griseoluteus that inhibits cancer invasion and metastasis.
Welch DR; Harper DE; Yohem KH
Clin Exp Metastasis; 1993 Mar; 11(2):201-12. PubMed ID: 8444012
[TBL] [Abstract][Full Text] [Related]
36. Periostin promotes ovarian cancer angiogenesis and metastasis.
Zhu M; Fejzo MS; Anderson L; Dering J; Ginther C; Ramos L; Gasson JC; Karlan BY; Slamon DJ
Gynecol Oncol; 2010 Nov; 119(2):337-44. PubMed ID: 20688362
[TBL] [Abstract][Full Text] [Related]
37. EFEMP1 promotes ovarian cancer cell growth, invasion and metastasis via activated the AKT pathway.
Yin X; Fang S; Wang M; Wang Q; Fang R; Chen J
Oncotarget; 2016 Jul; 7(30):47938-47953. PubMed ID: 27351229
[TBL] [Abstract][Full Text] [Related]
38. Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.
Zhang L; Zhang Y; Mehta A; Boufraqech M; Davis S; Wang J; Tian Z; Yu Z; Boxer MB; Kiefer JA; Copland JA; Smallridge RC; Li Z; Shen M; Kebebew E
Oncotarget; 2015 Apr; 6(11):9073-85. PubMed ID: 25940539
[TBL] [Abstract][Full Text] [Related]
39. Metformin inhibits the development and metastasis of ovarian cancer.
Wu B; Li S; Sheng L; Zhu J; Gu L; Shen H; La D; Hambly BD; Bao S; Di W
Oncol Rep; 2012 Sep; 28(3):903-8. PubMed ID: 22752027
[TBL] [Abstract][Full Text] [Related]
40. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.
Sadowski SM; Boufraqech M; Zhang L; Mehta A; Kapur P; Zhang Y; Li Z; Shen M; Kebebew E
Oncotarget; 2015 Jul; 6(20):18038-49. PubMed ID: 25945839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
